Business Context and Reporting Period
Company: Kewaunee Scientific Corporation
Filing Type: Form 10-Q (Quarterly Report)
Reporting Period: Three and nine months ended January 31, 1999
Business Overview: Manufacturer of laboratory and technical furniture. The company reported increased unit sales of laboratory furniture, offsetting a weaker technical furniture market.
Key Financial Metrics
| Metric ($ in thousands) | 9 Months Ended Jan 31, 1999 | 9 Months Ended Jan 31, 1998 | 3 Months Ended Jan 31, 1999 | 3 Months Ended Jan 31, 1998 |
|---|---|---|---|---|
| Net Sales | $57,281 | $53,437 | $18,404 | $17,333 |
| Gross Profit | $12,548 | $12,434 | $4,102 | $4,343 |
| Gross Margin | 21.9% | 23.3% | 22.3% | 25.1% |
| Operating Earnings | $3,440 | $2,909 | $1,102 | $998 |
| Net Earnings | $2,006 | $1,683 | $635 | $583 |
| Diluted EPS | $0.81 | $0.68 | $0.26 | $0.23 |
| Cash from Operations | ($443) | $440 | N/A | N/A |
| Capital Expenditures | ($2,969) | ($816) | N/A | N/A |
| Short-Term Borrowings | $2,422 | $0 | $2,422 | $0 |
| Working Capital | $9,492 | $9,566 | N/A | N/A |
Note: Working Capital calculated as Current Assets ($22,242) minus Current Liabilities ($12,750).
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 7.2% for the nine-month period and 6.2% for the quarter, driven by higher unit sales of laboratory furniture.
- Margin Compression: Gross profit margins declined (21.9% vs. 23.3% for nine months) due to start-up costs associated with new product lines.
- Expense Reduction: Operating expenses decreased as a percentage of sales (15.9% vs. 17.8%) due to reduced sales commissions and lower administrative expenses.
- Profitability: Net earnings rose 19.2% for the nine-month period despite margin pressure, aided by lower interest expense ($63k vs. $136k) due to reduced borrowings prior to the new facility.
- Cash Flow: Operating cash flow turned negative ($443k outflow) compared to a positive $440k inflow in the prior year, primarily due to increased receivables and reduced accounts payable.
- Capital Investment: Capital expenditures surged to $2.97 million (vs. $0.82 million prior year) to invest in computerized machinery for manufacturing efficiency.
Guidance, Outlook, and Risks
- Financing: Entered a new credit facility on January 6, 1999, replacing an expired $8.5M secured line. The new facility includes a $3M unsecured revolving component and a $5M equipment loan component. $2.4M was outstanding under the revolving component as of Jan 31, 1999.
- Liquidity: Management believes current sources (operations and credit facility) are sufficient for working capital needs. Current ratio is 1.74-to-1.
- Year 2000 Compliance: Main business applications are compliant; smaller applications are being addressed with a target compliance date of April 30, 1999. No significant costs are expected, but risks remain regarding supplier/customer compliance.
- Accounting Standards: SFAS No. 131 regarding segment disclosures will be adopted at the end of fiscal 1999; impact on reporting is currently being evaluated.
- Forward-Looking Statements: Results are subject to economic, competitive, and technological risks. Actual results may differ materially from expectations.
Investor Verification Checklist
- Verify the sustainability of the 7.2% sales growth given the noted weakness in the technical furniture market.
- Monitor the impact of new product line start-up costs on gross margins in subsequent quarters.
- Assess the return on the $2.97M capital expenditure for computerized machinery regarding cost reduction targets.
- Confirm the status of Year 2000 compliance for significant suppliers and customers to mitigate supply chain risks.
- Review the utilization of the new $3M revolving credit facility and adherence to financial covenants (tangible net worth, current ratio).